235108-11-9

Upstream product

• 1335097-24-9 C₁₉H₃₆O₂Si 
• 189102-18-9 des-A,B-8β-[(triethylsilyl)oxy]-22-(p-toluenesulfonyloxy)-23,24-dinorcholane 
• 66774-80-9 (S)-2-((3R,3aR,7S,7aR)-octahydro-7-hydroxy-3a-methyl-1H-inden-3-yl)propyl 4-methylbenzenesulfonate 
• 186372-30-5 (1R,3aR,4S,7aR)-octahydro-1-[(1’S)-1’-methyl-2’-oxo-ethanyl]-7a-methyl-4-triethylsilyloxy-1H-indene 
• 64190-52-9 (8S,20S)-de-A,B-20-(hydroxymethyl)pregnan-8-ol 
• 235107-97-8 (8S,20R)-des-A,B-8-[(triethylsilyl)oxy]-20-(hydroxymethyl)pregnane 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 1335097-70-5 (20R)-1α-[(tert-butyldimethylsilyl)oxy]-22,22-dimethyl-25-[(triethylsilyl)oxy]-2-methylene-19-norvitamin D(3) tert-butyldimethylsilyl ether 
• 1335097-71-6 (20R)-2-methylene-19-nor-22-dimethyl-1α,25-dihydroxyvitamin D₃ 
• 1335097-63-6 (20S)-2-methylene-19-nor-22-dimethyl-1α,25-dihydroxyvitamin D₃ 
• 1335097-62-5 (20S)-1α-[(tert-butyldimethylsilyl)oxy]-22,22-dimethyl-25-[(triethylsilyl)oxy]-2-methylene-19-norvitamin D(3) tert-butyldimethylsilyl ether 

Relevant academic research and scientific papers

(20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-HYDROXYVITAMIN D3

Compounds of formula I are provided where X1, X2 and X3 are independently selected from H or hydroxy protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a varie

DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1ALPHA,25-DIHYDROXYVITAMIN D3

Compounds of formula I are provided where X1, X2, and X3 are independently selected from H or hydroxy protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a vari